LEAMINGTON,
Ontario, June 07, 2022 (GLOBE NEWSWIRE) -- PRESS RELEASE--Tilray Brands, Inc.(Nasdaq: TLRY; TSX: TLRY), a
global cannabis and consumer packaged goods company, today
announced that its medical cannabis brand, Aphria, has launched CBN Night Oil, the brand’s
first CBN oil medical product formulated for patients’ nighttime use.
Blair MacNeil,
President, Tilray Canada, said, "Tilray Medical is committed to providing
patients in Canada and around the globe with safe, high-quality
cannabinoid-based medicine. We are pleased to add a dedicated night oil to the
Aphria medical portfolio and broaden our offering of effective medical cannabis
products to patients with a wider range of needs.”
CBN, or
cannabinol, is derived from THC and is known to help improve the duration and
quality of sleep. Aphria’s CBN-dominant oil is carefully formulated
with 30mg CBN per mL and 10mg THC per mL (in a 50mL bottle) and is composed of
broad-spectrum cannabis distillate. Designed to be used in conjunction with a
nighttime routine.
